By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cadila Pharmaceuticals 

Sarkhej-Dholka Road

Bhat  Ahmedabad  382 210  India
Phone: 91-2718-225001 Fax: 91-2718-225039



Company News
Lipidor And Cadila Pharmaceuticals Announce Agreement On Phase III Clinical Study And Joint Commercialization Of Topical Psoriasis Product 6/1/2016 9:07:34 AM
Moberg Pharma AB (Formerly known as Moberg Derma) And Cadila Pharmaceuticals Enters Agreement For Late-Stage Development And Commercialization Of BUPI 3/22/2016 11:08:08 AM
U.S. FDA Sends Warning Letter To Cadila Pharmaceuticals 11/12/2014 7:01:10 AM
Cadila Pharmaceuticals, Helperby Antibiotic Tie-Up Has Potential To Create Up To 1,000 New Jobs 11/15/2013 7:51:34 AM
Swedish Bactiguard AB to Enter Into an Exclusive Distribution Agreement With Cadila Pharmaceuticals 2/21/2012 10:15:57 AM
Novavax, Inc. (NVAX) Reports Progress Under Joint Venture in India With Cadila Pharmaceuticals 1/3/2012 9:41:04 AM
Cadila Pharmaceuticals Launches Joint Venture With Novavax, Inc. (NVAX) in India 7/9/2009 6:34:39 AM
Novavax, Inc. (NVAX) Announces Closing of $11 Million Common Stock Sale to Subsidiary of Cadila Pharmaceuticals 4/1/2009 11:13:05 PM
Novavax, Inc. (NVAX) Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 3/31/2009 11:50:04 PM
Eli Lilly and Company (LLY) Inks $300M R&D Pact with Cadila Pharmaceuticals 3/30/2009 11:11:50 AM